![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/78f7497b734e27ab339db2c98726aa7b.jpeg?width=720&quality=85%2C50)
1 minute read
MANAGEMENT
from Annual Report 2022
Deputy chair of the boards of H. Lundbeck A/S, ALK-Abelló A/S, Falck A/S and Ørsted A/S. Member of the board of Nordea Bank Abp
![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/67a813e9cde2c429f0db1d6a08602dbe.jpeg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/bb3f866f64c310ec491e7804489923e7.jpeg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/ad596e2eade13dd862a98133e4c8322e.jpeg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/824fe204b05111382f711d856c1589d0.jpeg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/180fea74377d91f4f6a5d29f61b21944.jpeg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/ec602b0ed7f32ebc97731e9e41f8ffa9.jpeg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/230328051328-6c61c160dea05974ad6be934c9c40526/v1/b942a6cbbfe279cdc823bd2f1754860e.jpeg?width=720&quality=85%2C50)
Holds 61,270 B-shares in H. Lundbeck A/S and 23,000 shares in ALK-Abelló A/S
Chair of the board of Cresco Capital Services A/S and deputy chair of the board of Obel-LFI Ejendomme A/S. Member of the boards of LFI Silva Investments A/S and Ferrosan Medical Devices Group
Chair of the boards of SNIPR Holdings ApS, SNIPR Biome ApS and CytoKi Pharma ApS. Member of the boards of Afyx Therapeutics A/S, IO Biotech, Inc, NMD Pharma A/S and 7TM A/S
Member of the boards of Louisiana Museum of Modern Art and CfL